Latest News
Alector, Inc.
- Alector, Inc. Estimates – MUN:0Z2
- Alector, Genentech Ink Deal for Parkinson Therapy AL050
- Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal
- Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech
- Alector licenses brain-penetrant GCase therapy to Genentech in deal worth up to $1.27bn
- Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion
- Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
- Genentech pays Alector $100M for preclinical Parkinson’s prospect
- Roche licenses Alector's brain-penetrant Parkinson's therapy for up to $1.3B
- Alector Enters Global License Agreement with Genentech for
- Alector signs $1.27 billion global licensing deal with Genentech
- Alector secures USD 100m upfront from Genentech for brain-penetrant GCase therapy in Parkinson's disease
Headlines from the last 30 days, linking to the original publishers. See all market news →